Figure 2.
STK4 protein expression in relation to tumor clinicopathological characteristics. The Kruskal-Walli’s test was applied in all cases with respective exact p-values reported in the figure. (A) STK4 is expressed at higher levels in Type 1 tumors, than in Type 2 samples; (B) STK4 protein levels are decreasing with the advanced tumor grade; (C) This observation (in B) became more clear when serous tumors were included in statistical calculations; (D) No significant differences were observed in SKT4 expression, when it was related to the tumor stage; (E) A slight decrease in STK4 expression upon tumor progression was detected, when serous tumors were included in calculations.
